DEVELOPMENT AND EVALUATION OF SUBLINGUAL TABLET OF ZOLPIDEM TARTRATE AN ANTIPSYCHOTIC DRUG
Objective: The present work aims to develop and evaluate sublingual tablets of Zolpidem Tartrate used for the short-term treatment of insomnia.
Methods: The tablet of Zolpidem Tartrate was prepared by direct compression technique using two classes of super disintegrates represented by Crospovidone and Sodium Starch Glycolate (SSG) and the efficiency of these super disintegrants in the tablets was compared with various tests like disintegration time, waiting time, water absorption ratio, in-vitro dissolution profile and stability study.
Results: The disintegration efficiency of Crospovidone is better than SSG. Fourier Transform Infrared (FT-IR) spectrum of pure drug and the mixture of drug polymers revealed no chemical interaction. The pre-compression study indicated good flow properties of the bulk powder. In-vitro drug release from the formulations was studied using buffer pH 6.8. From the entire formulations, F5 and F6 containing 4 % and 5 % of Crospovidone conceded as an optimized formulation which is showing the drug release of 102.00Â±0.21 % and 103.10Â±0.42 % in 30 min considerably.
Conclusion: The results indicated that delivery of Zolpidem Tartrate into the systemic circulation via the sublingual route to improving its bio-availability and circumvent the first-pass effect. The optimized formulations were also found to be stable during stability studies conducted for 3 mg as per ICH guidelines.Keywords: Insomnia, Zolpidem Tartrate, Crospovidone, Sodium Starch Glycolate, In-vitro disintegration, In-vitrodrug release, Sublingual tablet
2. Manish RB. Development and evaluation of film coated extended-release zolpidem tartrate tablet by direct compression technology. Asian J Pharm Clin Res 2012;5 Suppl 3:82-5.
3. Meda Pharmaceuticals Inc. US Patent 6761910; 1992.
4. Introduction of Psychotropic Substances. Available from: http://shodhganga.inflibnet.ac.in. [Last accessed on 20 Sep 2015].
5. http://www.drugbank.ca/drugs/DB00425. [Last accessed on 20 Sep 2015].
6. Neha N, Jyoti S. Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci 2011;3 Suppl 2:18-22.
7. Birudaraj R, Berner B, Shen S, Li X. Buccal permeation of buspirone: mechanistic studies on transport pathways. J Pharm Sci 2005;94:70-8.
8. Ishikawa T, Koizumi N, Mukai B, Utoguchi N, Fujii M, Matsumoto M, et al. Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules. Chem Pharm Bull 2001;49:230-2.
9. Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW. Single dose pharmacokinetics of sublingual versus oral administration of micronized 17 Beta-estradiol. Obstet Gynecol 1997;89:340-5.
10. Patel HP, Karwa P, Rama B, Patel NJ. Formulation and evaluation of immediate release tablets of zolpidem tartrate by direct compression. Int J Pharm Sci Rev Res 2011;7:80-5.
11. Bala R, Seth N, Yogesh B, Sharma S. Development and characterization of taste masked mouth dissolving tablets of zolpidem tartrate. Int Res J Pharm 2010;1:417-27.
12. Lachman L, Lieberman HA, King JL. The theory and practice of industrial pharmacy. 3rd ed. Bombay (IND): Varghese Publishing House; 1987.
13. Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Lida K. Preparation and evaluation of compressed tablets rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo) 1996;44:2121-7.
14. Singh M, Chitranshi N, Singh AP, Arora V, Siddiqi AW. An overview on fast disintegrating sublingual tablets. Int J Drug Delivery 2012;4:407-17.
15. Mittal SS, Dholariya YN, Patidar MK, Soni SB, Rathi SA, Bhingare CL. Formulation and evaluation of mouth dissolving tablet of zolpidem tartrate. Int J Pharm Res Rev 2013;2:1-8.
16. ICH Harmonized Tripartite Guideline. Stability Testing for New Dosage Forms: Q1C; 1996.
17. Lieberman H, Lachman L, Schwartz J. Pharmaceutical Dosage Form: Tablets. Vol. 1. 2nd ed. New York: Marcel deffer; 1989. p. 214-20.
18. Aultan M. The science of dosage form design. 2nd ed. Spain: Churchill Livingstone; 2001. p. 133-5.
19. Indian Pharmacopoeia. Vol. 1. Ghaziabad: Ministry of health and Family Welfare Government of India; 2007. p. 177-83.